Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Renagel/Renvela
Main Therapeutic Indication : Nephrology
Currency : USD
2019 Revenue in Millions : 339
2018 Revenue in Millions : 448
Growth (%) : -24
Sevelamer Hydrochloride and Sevelamer Carbonate
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 288
2019 Revenue in Millions : 376
Growth (%) : -23
LOOKING FOR A SUPPLIER?